...
首页> 外文期刊>BMC Neurology >Arthropathy-related pain in a patient with congenital impairment of pain sensation due to hereditary sensory and autonomic neuropathy type II with a rare mutation in the WNK1/HSN2 gene: a case report
【24h】

Arthropathy-related pain in a patient with congenital impairment of pain sensation due to hereditary sensory and autonomic neuropathy type II with a rare mutation in the WNK1/HSN2 gene: a case report

机译:遗传性感官和自主神经病II型伴有WNK1 / HSN2基因罕见突变的先天性疼痛感受损患者的关节炎相关疼痛:病例报告

获取原文
           

摘要

Background Hereditary sensory and autonomic neuropathy (HSAN) type II with WNK1/HSN2 gene mutation is a rare disease characterized by early-onset demyelination sensory loss and skin ulceration. To the best of our knowledge, no cases of an autonomic disorder have been reported clearly in a patient with WNK/HSN2 gene mutation and only one case of a Japanese patient with the WNK/HSN2 gene mutation of HSAN type II was previously reported. Case presentation Here we describe a 54-year-old woman who had an early childhood onset of insensitivity to pain; superficial, vibration, and proprioception sensation disturbances; and several symptoms of autonomic failure (e.g., orthostatic hypotension, fluctuation in body temperature, and lack of urge to defecate). Genetic analyses revealed compound homozygous mutations in the WNK1/HSN2 gene (c.3237_3238insT; p.Asp1080fsX1). The patient demonstrated sensory loss in the “stocking and glove distribution” but could perceive visceral pain, such as menstrual or gastroenteritis pain. She experienced frequent fainting episodes. She had undergone exenteration of the left metatarsal because of metatarsal osteomyelitis at 18 years. Sural nerve biopsy revealed a severe loss of myelinated and unmyelinated nerves. She complained of severe pain in multiple joints, even on having pain impairment. Although non-steroidal anti-inflammatory drugs are generally more effective than acetaminophen for arthritis, in our case, they were ineffective and acetaminophen (2400 mg/day) adequately controlled her pain and improved quality of life. Over 3 months, the numerical rating scale, pain interference scale of the Brief Pain Inventory, and the Pain Catastrophizing Scale decreased from 6/10 to 3/10, from 52/70 to 20/70, and from 22/52 to 3/52 points, respectively. Conclusions This is the second reported case of a Japanese patient with WNK/HSN2 gene mutation of HSAN type II and the first reported case of an autonomic disorder in a patient with the WNK/HSN2 gene mutation. Acetaminophen adequately controlled arthropathy related pain in a patient with congenital impairment of pain sensation.
机译:背景带有WNK1 / HSN2基因突变的II型遗传性感觉和自主神经病(HSAN)是一种罕见疾病,其特征在于早发性脱髓鞘性感觉丧失和皮肤溃疡。据我们所知,尚无WNK / HSN2基因突变患者的自主神经疾病病例的明确报道,而以前仅报道了HSAN II型WNK / HSN2基因突变的日本患者的病例。案例介绍在这里,我们描述了一个54岁的女性,她从小就开始对疼痛不敏感。表面,振动和本体感觉障碍;以及一些自主神经功能衰竭的症状(例如体位性低血压,体温波动以及缺乏排便的冲动)。遗传分析显示WNK1 / HSN2基因(c.3237_3238insT; p.Asp1080fsX1)中的化合物纯合突变。患者在“放养和手套分配”中表现出感觉缺失,但可能会感觉到内脏疼痛,例如月经或肠胃炎疼痛。她经历了频繁的晕厥发作。由于meta骨骨髓炎,她在18岁时经历了左meta骨的抽出。神经神经活检显示髓鞘和非髓鞘神经严重丧失。她抱怨说,即使有疼痛障碍,也有多个关节剧烈疼痛。尽管非甾体类抗炎药通常比对乙酰氨基酚对关节炎更有效,但在我们的案例中,它们无效,对乙酰氨基酚(2400 mg /天)足以控制她的疼痛并改善生活质量。在3个月内,简短疼痛量表的数字评分量表,疼痛干预量表和疼痛灾难性量表从6/10降低到3/10,从52/70降低到20/70,从22/52降低到3 /分别为52分。结论这是第二例日本人HSAN II型WNK / HSN2基因突变的病例,也是第一例WNK / HSN2基因突变患者的植物神经疾病。对乙酰氨基酚可充分控制先天性疼痛感觉受损患者的与关节炎相关的疼痛。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号